Form 8-K - Current report:
SEC Accession No. 0001193125-19-267593
Filing Date
2019-10-15
Accepted
2019-10-15 14:10:39
Documents
2
Period of Report
2019-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d820794d8k.htm 8-K 20926
2 EX-10.1 d820794dex101.htm EX-10.1 281421
  Complete submission text file 0001193125-19-267593.txt   303535
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 191150587
SIC: 2834 Pharmaceutical Preparations